India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body says

India’s pharmaceutical industry will likely miss its 2030 sales target due to shipping issues and U.S. tariff uncertainty. Namit Joshi said, "I don't foresee us achieving that growth target." The sector now expects $80 billion to $90 billion in sales, falling short of the $130 billion goal set last April.